Haemonetics Corp Q1 FY2023 Earnings Call

Haemonetics Corp (HAE)

Earnings Call FY2023 Q1 Call date: 2022-08-10 Concluded

Quarter scorecard

Revenue

$261.46M

+14.4% YoY

Diluted EPS

$0.38

Gross margin

54.4%

+7.1 pp YoY

Net income

$19.88M

Plasma Products and Services $118.35M

+30.8%

Hospital Products and Services $90.19M

+12.4%

Blood Center Products and Services $52.92M

-8.4%

Service $4.89M